Bank of America
IMRX icon

Bank of America’s Immuneering IMRX Stock Holding History

Bank of America’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$795K Sell
150,847
-63,494
-30% -$325K ﹤0.01% 4634
2025
Q4 		$1.41M Buy
214,341
+170,587
+390% +$1.1M ﹤0.01% 4312
2025
Q3 		$306K Buy
43,754
+15,262
+54% +$79.2K ﹤0.01% 6070
2025
Q2 		$96K Sell
28,492
-362
-1% -$620 ﹤0.01% 6533
2025
Q1 		$43.9K Sell
28,854
-2,200
-7% -$4K ﹤0.01% 6782
2024
Q4 		$68.3K Sell
31,054
-333
-1% -$691 ﹤0.01% 6540
2024
Q3 		$78.2K Sell
31,387
-728
-2% -$1.06K ﹤0.01% 6423
2024
Q2 		$41.1K Buy
32,115
+19,112
+147% +$31.4K ﹤0.01% 6566
2024
Q1 		$37.6K Sell
13,003
-11,401
-47% -$63.9K ﹤0.01% 6597
2023
Q4 		$179K Buy
24,404
+12,587
+107% +$83.9K ﹤0.01% 6120
2023
Q3 		$90.8K Buy
11,817
+7,103
+151% +$65.3K ﹤0.01% 6292
2023
Q2 		$47.8K Buy
4,714
+2,322
+97% +$22.3K ﹤0.01% 6478
2023
Q1 		$23.2K Buy
2,392
+1,861
+350% +$10.6K ﹤0.01% 6726
2022
Q4 		$2.58K Buy
531
+493
+1,297% +$4.37K ﹤0.01% 7184
2022
Q3 		$1K Sell
38
-853
-96% -$6.77K ﹤0.01% 7674
2022
Q2 		$4K Sell
891
-28,413
-97% -$152K ﹤0.01% 7644
2022
Q1 		$189K Buy
29,304
+21,572
+279% +$207K ﹤0.01% 6502
2021
Q4 		$125K Buy
7,732
+7,190
+1,327% +$175K ﹤0.01% 6769
2021
Q3 		$14K Buy
+542
New +$14.6K ﹤0.01% 7488

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America's IMRX Position: Q1 2026 in Review

Bank of America reduced its Immuneering (IMRX) stake by 30% in Q1 2026, selling an estimated $325K and leaving 150,847 shares worth $795K. The position accounts for ﹤0.01% of the portfolio, ranked #4634.

Bank of America first reported a position in IMRX in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.41M in Q4 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • Bank of America held 150,847 shares of Immuneering worth $795K as of Q1 2026.
  • Bank of America sold 63,494 Immuneering shares in Q1 2026, an estimated $325K.
  • Immuneering made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4634 holding.
  • Bank of America first reported a position in Immuneering in Q3 2021 and has held it in 19 quarters since.
  • Bank of America's Immuneering position peaked at $1.41M in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.